Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Scodes

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Substance Abuse Treatment|March 27, 2021
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failureMatisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.
Journal of Substance Abuse Treatment|June 7, 2021
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapseMiranda G Greiner, Matisyahu Shulman, Tse-Hwei Choo, et al.
Journal of Addiction Medicine|August 14, 2023
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOTMarissa Justen, Jennifer Scodes, Martina Pavlicova, et al.
Journal of Substance Abuse Treatment|August 9, 2021
Corrigendum to "Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse" [Journal of Substance Abuse Treatment 131 (2021) 108447]Miranda G Greiner, Matisyahu Shulman, Tse-Hwei Choo, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 25, 2018
Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled TrialDavangere P Devanand, Gregory H Pelton, Kristina D'Antonio, et al.
Psychiatric Services (Washington, D.C.)|May 16, 2018
Results of a Coordinated Specialty Care Program for Early Psychosis and Predictors of OutcomesIlana Nossel, Melanie M Wall, Jennifer Scodes, et al.
Substance Use & Misuse|August 17, 2022
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable NaltrexoneMiranda G Greiner, Matisyahu Shulman, Jennifer Scodes, et al.
Psychiatric Services (Washington, D.C.)|December 3, 2020
Design of a Payment Decision-Support Tool for Coordinated Specialty Care for Early PsychosisYuhua Bao, Yan Li, Philip J Jeng, et al.
Drug and Alcohol Dependence Reports|January 16, 2023
Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorderKathryn Hefner, Tse-Hwei Choo, Dikla Shmueli-Blumberg, et al.
The American Journal on Addictions|August 15, 2018
Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trialAimee N C Campbell, Celestina Barbosa-Leiker, Mary Hatch-Maillette, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Substance Abuse Treatment|March 27, 2021
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failureMatisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.
Journal of Substance Abuse Treatment|June 7, 2021
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapseMiranda G Greiner, Matisyahu Shulman, Tse-Hwei Choo, et al.
Journal of Addiction Medicine|August 14, 2023
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOTMarissa Justen, Jennifer Scodes, Martina Pavlicova, et al.
Journal of Substance Abuse Treatment|August 9, 2021
Corrigendum to "Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse" [Journal of Substance Abuse Treatment 131 (2021) 108447]Miranda G Greiner, Matisyahu Shulman, Tse-Hwei Choo, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 25, 2018
Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled TrialDavangere P Devanand, Gregory H Pelton, Kristina D'Antonio, et al.
Psychiatric Services (Washington, D.C.)|May 16, 2018
Results of a Coordinated Specialty Care Program for Early Psychosis and Predictors of OutcomesIlana Nossel, Melanie M Wall, Jennifer Scodes, et al.
Substance Use & Misuse|August 17, 2022
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable NaltrexoneMiranda G Greiner, Matisyahu Shulman, Jennifer Scodes, et al.
Psychiatric Services (Washington, D.C.)|December 3, 2020
Design of a Payment Decision-Support Tool for Coordinated Specialty Care for Early PsychosisYuhua Bao, Yan Li, Philip J Jeng, et al.
Drug and Alcohol Dependence Reports|January 16, 2023
Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorderKathryn Hefner, Tse-Hwei Choo, Dikla Shmueli-Blumberg, et al.
The American Journal on Addictions|August 15, 2018
Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trialAimee N C Campbell, Celestina Barbosa-Leiker, Mary Hatch-Maillette, et al.
Pageof 5